AR041263A1 - El uso de inhibidores de la pde iv para la manufactura de un medicamento para el tratamiento de la angiogenesis - Google Patents
El uso de inhibidores de la pde iv para la manufactura de un medicamento para el tratamiento de la angiogenesisInfo
- Publication number
- AR041263A1 AR041263A1 ARP030103340A ARP030103340A AR041263A1 AR 041263 A1 AR041263 A1 AR 041263A1 AR P030103340 A ARP030103340 A AR P030103340A AR P030103340 A ARP030103340 A AR P030103340A AR 041263 A1 AR041263 A1 AR 041263A1
- Authority
- AR
- Argentina
- Prior art keywords
- angiogenesis
- manufacture
- treatment
- pde
- inhibitors
- Prior art date
Links
- 230000033115 angiogenesis Effects 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 206010030113 Oedema Diseases 0.000 abstract 1
- 208000037765 diseases and disorders Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000001525 retina Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41100102P | 2002-09-16 | 2002-09-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR041263A1 true AR041263A1 (es) | 2005-05-11 |
Family
ID=31994234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030103340A AR041263A1 (es) | 2002-09-16 | 2003-09-15 | El uso de inhibidores de la pde iv para la manufactura de un medicamento para el tratamiento de la angiogenesis |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20040053939A1 (https=) |
| EP (1) | EP1539174A4 (https=) |
| JP (1) | JP2006501269A (https=) |
| KR (1) | KR20050043923A (https=) |
| CN (1) | CN1681510A (https=) |
| AR (1) | AR041263A1 (https=) |
| AU (1) | AU2003267161A1 (https=) |
| BR (1) | BR0314364A (https=) |
| CA (1) | CA2497192A1 (https=) |
| MX (1) | MXPA05002146A (https=) |
| PL (1) | PL374659A1 (https=) |
| TW (1) | TW200412972A (https=) |
| WO (1) | WO2004024085A2 (https=) |
| ZA (1) | ZA200501477B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2851247B1 (fr) * | 2003-02-19 | 2007-06-29 | Exonhit Therapeutics Sa | Methodes et compositions pour le traitement de pathologies degeneratives oculaires |
| SI1755616T1 (sl) * | 2004-04-08 | 2014-04-30 | Eye Co Pty Ltd. | Zdravljenje eksudativne retinopatije z mineralkortikoidi |
| WO2007056457A2 (en) | 2005-11-09 | 2007-05-18 | Combinatorx, Incorporated | Methods, compositions, and kits for the treatment of medical conditions |
| EP2117524B8 (en) * | 2007-01-29 | 2019-09-25 | National Research Council of Canada | Use of catecholamines and related compounds as anti-angiogenic agents |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2570579B1 (fr) * | 1984-09-26 | 1987-01-09 | Salomon Sa | Dispositif de fermeture et de serrage d'une chaussure de ski a ouverture arriere |
| US4975537A (en) * | 1985-10-23 | 1990-12-04 | The Upjohn Company | Δ9(11) -angiostatic steroids |
| US4771042A (en) * | 1985-11-25 | 1988-09-13 | The Upjohn Company | Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments |
| GB9413975D0 (en) * | 1994-07-11 | 1994-08-31 | Fujisawa Pharmaceutical Co | New heterobicyclic derivatives |
| US5605914A (en) * | 1993-07-02 | 1997-02-25 | Celgene Corporation | Imides |
| GB9603095D0 (en) * | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
| AU6823098A (en) * | 1997-02-28 | 1998-09-18 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
| US5866872A (en) * | 1997-07-25 | 1999-02-02 | Hypertherm, Inc. | Plasma arc torch position control |
| DE19812515A1 (de) * | 1998-03-21 | 1999-09-23 | M & F Entw & Patentverwertungs | Lamellenschleifwerkzeug |
| HK1042896A1 (zh) * | 1998-09-29 | 2002-08-30 | 藤泽药品工业株式会社 | 吡啶并吡嗪化合物的新的盐及其结晶 |
| US6740664B2 (en) * | 1998-09-30 | 2004-05-25 | Alcon, Inc. | Methods for treating otic and ophthalmic infections |
| US6326888B1 (en) * | 1998-12-17 | 2001-12-04 | Ching-Yung Wang | Auxiliary safety warning light system for a vehicle |
| US6326388B1 (en) * | 1999-12-21 | 2001-12-04 | Celgene Corporation | Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level |
| AR030345A1 (es) * | 2000-08-14 | 2003-08-20 | Alcon Inc | Metodo de tratamiento de desordenes relacionados con angiogenesis |
-
2003
- 2003-09-11 KR KR1020057003469A patent/KR20050043923A/ko not_active Withdrawn
- 2003-09-11 MX MXPA05002146A patent/MXPA05002146A/es unknown
- 2003-09-11 ZA ZA200501477A patent/ZA200501477B/en unknown
- 2003-09-11 AU AU2003267161A patent/AU2003267161A1/en not_active Abandoned
- 2003-09-11 PL PL03374659A patent/PL374659A1/xx not_active Application Discontinuation
- 2003-09-11 EP EP03749635A patent/EP1539174A4/en not_active Ceased
- 2003-09-11 US US10/660,152 patent/US20040053939A1/en not_active Abandoned
- 2003-09-11 CN CNA038215454A patent/CN1681510A/zh active Pending
- 2003-09-11 US US10/527,599 patent/US20060014782A1/en not_active Abandoned
- 2003-09-11 WO PCT/US2003/028675 patent/WO2004024085A2/en not_active Ceased
- 2003-09-11 BR BR0314364-3A patent/BR0314364A/pt not_active IP Right Cessation
- 2003-09-11 CA CA002497192A patent/CA2497192A1/en not_active Abandoned
- 2003-09-11 JP JP2004536198A patent/JP2006501269A/ja active Pending
- 2003-09-15 AR ARP030103340A patent/AR041263A1/es not_active Application Discontinuation
- 2003-09-15 TW TW092125341A patent/TW200412972A/zh unknown
-
2005
- 2005-08-16 US US11/204,938 patent/US20050277648A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003267161A1 (en) | 2004-04-30 |
| US20060014782A1 (en) | 2006-01-19 |
| MXPA05002146A (es) | 2005-05-23 |
| PL374659A1 (en) | 2005-10-31 |
| EP1539174A4 (en) | 2006-10-25 |
| WO2004024085A3 (en) | 2004-04-29 |
| KR20050043923A (ko) | 2005-05-11 |
| CA2497192A1 (en) | 2004-03-25 |
| TW200412972A (en) | 2004-08-01 |
| US20050277648A1 (en) | 2005-12-15 |
| BR0314364A (pt) | 2005-07-19 |
| ZA200501477B (en) | 2006-10-25 |
| WO2004024085A2 (en) | 2004-03-25 |
| US20040053939A1 (en) | 2004-03-18 |
| CN1681510A (zh) | 2005-10-12 |
| JP2006501269A (ja) | 2006-01-12 |
| EP1539174A2 (en) | 2005-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022006672A (es) | Compuestos bifuncionales para la degradacion de btk a traves de la via de proteosomas de ubiquitina. | |
| DE602004032149D1 (de) | Oros-push-stick für die kontrollierte abgabe von wirkstoffen | |
| MX2020012180A (es) | Compuestos biciclicos fusionados utiles como inhibidores de la peptidasa 30 especifica de ubiquitina. | |
| AR048833A1 (es) | Procedimiento para el tratamiento de trastornos premenstruales y otros trastornos sexuales femeninos | |
| AR037109A1 (es) | Uso de flibanserina | |
| AR062402A1 (es) | Uso de compuestos y derivados de 2,5-dihidroxibenceno para el tratamiento del cancer de piel | |
| HRP20040758B1 (hr) | Uporaba il-18 inhibitora za lijeäśenje i/ili prevenciju perifernih krvožilnih bolesti | |
| CY1114448T1 (el) | Φαρμακευτικες συνθεσεις και χρηση αυτων στην αγωγη της γυναικειας σεξουαλικης δυσλειτουργιας | |
| ATE388708T1 (de) | Piperazinderivate und anwendungsverfahren | |
| DE60320095D1 (de) | Zusammensetzungen zur behandlung von hauterkrankungen | |
| NZ517038A (en) | Use of serotonin reuptake inihibitor in medicaments for treating sexual dysfunction | |
| MX2024000947A (es) | Compuestos bifuncionales para degradar btk con actividad de imid mejorada. | |
| NO20043792L (no) | New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine | |
| BR0206549A (pt) | Uso de flumazenil na produção de uma droga para o tratamento de dependência de álcool | |
| AR023687A1 (es) | Una composicion para el tratamiento de desordenes de la retina externa y el uso de un antagonista de glutamato para la manufactura de un medicamento parael tratamiento de desordenes de la retina externa | |
| AR076505A1 (es) | Uso de alopurinol para el tratamiento de la reaccion cutanea en manos -pies | |
| AR041263A1 (es) | El uso de inhibidores de la pde iv para la manufactura de un medicamento para el tratamiento de la angiogenesis | |
| PA8525801A1 (es) | Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2 | |
| CO2023009316A2 (es) | Derivados de imidazo[1,2-a]piridinilo como inhibidores de irak4 y su uso en el tratamiento de enfermedades | |
| GT200500366A (es) | Tiazolidinonas metasustituidas, su preparacion y su uso como medicamento | |
| ES2125356T3 (es) | Empleo de leflunomida para la inhibicion de interleuquina 8. | |
| AR019322A1 (es) | Derivados de sulfonilo sustituido por heterociclo-etanodionanilina sustituida por heterociclo, composicion farmaceutica que los contiene y su uso para lamanufactura de un medicamento | |
| BR112022008610A2 (pt) | Composições tópicas compreendendo inibidores de irak4 para uso em tratamento de condições dermatológicas caracterizadas por inflamação | |
| ES2192810T3 (es) | Empleo de monoxidina como medicamento de actividad estimulante de la termogenesis. | |
| AR023452A1 (es) | Utilizacion del osanetant para preparacion de medicamentos utiles en el tratamiento de los trastornos del humor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |